{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:40:29Z","timestamp":1761864029333,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.amjcard.2019.07.033","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:22:20Z","timestamp":1564492940000},"page":"1226-1231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart Failure"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-6355","authenticated-orcid":false,"given":"Peter A.","family":"McCullough","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirsch S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin M.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Cork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-585X","authenticated-orcid":false,"given":"Candace","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Van Houten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mollenkopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Verta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.07.033_bib0001","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.amjcard.2019.07.033_bib0002","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/europace\/eur081","article-title":"What are the costs of heart failure?","volume":"13","author":"Braunschweig","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0003","first-page":"5","article-title":"Integration of cardiac biomarkers into a disease-specific score and its relation to intensity of medical therapy","volume":"1","author":"Vasudevan","year":"2017","journal-title":"Heart Circ"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","article-title":"Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction","volume":"11","author":"Agricola","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.amjcard.2017.07.023","article-title":"Functional mitral regurgitation predicts short-term adverse events in patients with acute heart failure and reduced left ventricular ejection fraction","volume":"120","author":"De la Espriella","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0006","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.amjcard.2017.05.051","article-title":"Ischemic or nonischemic functional mitral regurgitation and outcomes in patients with acute decompensated heart failure with preserved or reduced ejection fraction","volume":"120","author":"Kajimoto","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0007","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0008","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0009","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(16)00558-4","article-title":"Mitral valve disease\u2013current management and future challenges","volume":"387","author":"Nishimura","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0011","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11897-010-0006-8","article-title":"Percutaneous mitral valve repair: potential in heart failure management","volume":"7","author":"Hussaini","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1540-8191.2011.01274.x","article-title":"Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development","volume":"26","author":"de Marchena","year":"2011","journal-title":"J Card Surg"},{"year":"2014","series-title":"Health Research Data for the Real World: The MarketScan\u00ae Databases","author":"Danielson","key":"10.1016\/j.amjcard.2019.07.033_bib0014"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0735-1097(01)01700-4","article-title":"Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study","volume":"39","author":"McCullough","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0017","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jchf.2017.06.015","article-title":"Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction","volume":"5","author":"Nasser","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0018","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0019","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15420\/icr.2018.40.1","article-title":"Why did COAPT win while MITRA-FR failed? Defining the appropriate patient population for MitraClip","volume":"14","author":"Atianzar","year":"2019","journal-title":"Interv Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0021","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2017.04.012","article-title":"Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients","volume":"189","author":"Vemulapalli","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.07.033_bib0022","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.acvd.2014.09.008","article-title":"Economic burden of functional and organic mitral valve regurgitation","volume":"108","author":"Trochu","year":"2015","journal-title":"Arch Cardiovasc Dis"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919308331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919308331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:30:28Z","timestamp":1757572228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919308331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0002914919308331"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.07.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}